Cargando…

Neuronal pentraxin II is highly upregulated in Parkinson’s disease and a novel component of Lewy bodies

Neuronal pentraxin II (NPTX2) is the most highly upregulated gene in the Parkinsonian substantia nigra based on our whole genome expression profiling results. We show here that it is a novel component of Lewy bodies and Lewy neurites in sporadic Parkinson’s disease (PD). NPTX2 is also known as the n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moran, Linda B., Hickey, Lorraine, Michael, Gregory J., Derkacs, Maria, Christian, Lynne M., Kalaitzakis, Michail E., Pearce, Ronald K. B., Graeber, Manuel B.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2007
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270353/ https://www.ncbi.nlm.nih.gov/pubmed/17987278 http://dx.doi.org/10.1007/s00401-007-0309-3

Ejemplares similares

Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
por: Liu, Alan King Lun, et al.
Publicado: (2019)

Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation
por: Moran, Linda B., et al.
Publicado: (2008)

Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease
por: Pey, Peixuan, et al.
Publicado: (2014)

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
por: Croisier, Emilie, et al.
Publicado: (2005)

Correction: Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
por: Croisier, Emilie, et al.
Publicado: (2006)

An interventional study of baicalin on neuronal pentraxin-1, neuronal pentraxin-2, and C-reactive protein in Alzheimer’s disease rat model
por: Zhao, Jing-Kun, et al.
Publicado: (2023)

Critical role of extracellularly secreted neuronal pentraxin 1 in ischemic neuronal death
por: Thatipamula, Shabarish, et al.
Publicado: (2014)

Neuronal Pentraxin 2 Binds PNNs and Enhances PNN Formation
por: Van't Spijker, Heleen M., et al.
Publicado: (2019)

The Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs
por: Pepys, Mark. B.
Publicado: (2018)

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
por: van der Ende, Emma L, et al.
Publicado: (2020)

The Role of Neuronal Pentraxin 2 (NP2) in Regulating Glutamatergic Signaling and Neuropathology
por: Chapman, Georgina, et al.
Publicado: (2020)

Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson’s Disease-like Dementia
por: Ejlerskov, Patrick, et al.
Publicado: (2015)

Regulation of pentraxin-3 by antioxidants
por: Hill, A. L., et al.
Publicado: (2009)

Pentraxins in Complement Activation and Regulation
por: Ma, Ying Jie, et al.
Publicado: (2018)

Regulation of the Complement System by Pentraxins
por: Haapasalo, Karita, et al.
Publicado: (2019)

Pentraxin 3 in Cardiovascular Disease
por: Ristagno, Giuseppe, et al.
Publicado: (2019)

Structural recognition and functional activation of FcγR by innate pentraxins
por: Lu, Jinghua, et al.
Publicado: (2008)

Pentraxin 3 innately preps damaged tissue for wound healing
por: Rua, Rejane, et al.
Publicado: (2015)

Tunicamycin-induced Endoplasmic Reticulum Stress Upregulates the Expression of Pentraxin 3 in Human Retinal Pigment Epithelial Cells
por: Hwang, Narae, et al.
Publicado: (2016)

Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2020)

Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration
por: Gómez de San José, Nerea, et al.
Publicado: (2021)

Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson’s disease and co-localises with Lewy bodies
por: Pamphlett, Roger, et al.
Publicado: (2022)

Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C‐reactive protein, for clinical use
por: Pepys, Mark B., et al.
Publicado: (2012)

Differential expression of galanin in the cholinergic basal forebrain of patients with Lewy body disorders
por: Alexandris, Athanasios, et al.
Publicado: (2015)

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
por: Riederer, Peter, et al.
Publicado: (2023)

LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson’s disease and dementia with Lewy bodies
por: Grochowska, Martyna M., et al.
Publicado: (2021)

A case of Lewy body disease and anaplastic astrocytoma presenting with atypical parkinsonism
por: Leahy, Christopher B, et al.
Publicado: (2022)

β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice
por: Coltrini, Daniela, et al.
Publicado: (2022)

Silencing circular RNA circ_0054537 and upregulating microRNA-640 suppress malignant progression of renal cell carcinoma via regulating neuronal pentraxin-2 (NPTX2)
por: Pei, Long, et al.
Publicado: (2021)

Genetic analysis of the pentraxin genes in SLE
por: Russell, AI, et al.
Publicado: (2001)

Pentraxin 3: An Immuno-Regulator in the Lungs
por: Balhara, Jyoti, et al.
Publicado: (2013)

Pentraxins: Structure, Function, and Role in Inflammation
por: Du Clos, Terry W.
Publicado: (2013)

Serum pentraxin 3 concentrations in neonates
por: Lannergård, Anders, et al.
Publicado: (2014)

The role of pentraxin 3 in pemphigus vulgaris
por: Halil Yavuz, Ibrahim, et al.
Publicado: (2019)

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression
por: Begcevic, Ilijana, et al.
Publicado: (2018)

Neuropathic pain-induced cognitive dysfunction and down-regulation of neuronal pentraxin 2 in the cortex and hippocampus
por: Wang, Rongguo, et al.
Publicado: (2021)

LRRK2 in Parkinson's disease and dementia with Lewy bodies
por: Zhu, Xiongwei, et al.
Publicado: (2006)

Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
por: Pagan, Fernando, et al.
Publicado: (2016)

Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
por: Koeglsperger, Thomas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_paffiv6mktp0ffeisq1p2r02m5